James George Chopas
VP/Chief Accounting Officer · 4 filings · Latest: May 14, 2026
Apellis Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
APLS | James George Chopas | VP/Chief Accounting Officer | Jan 22, 2026 | Sale | $21.77 | 2,064 | $44.9K | 49,805 | |
APLS | Chopas James George | — | Jan 22, 2026 | Proposed Sale | $21.77 | 2,064 | $44.9K | — | |
APLS | James George Chopas | VP/Chief Accounting Officer | Jan 20, 2026 | Sale | $19.79 | 726 | $14.4K | 51,869 | |
APLS | Chopas James George | — | Jan 20, 2026 | Proposed Sale | $19.79 | 726 | $14.4K | — | |
APLS | Chopas James George | — | Jan 13, 2026 | Proposed Sale | $22.19 | 873 | $19.4K | — | |
APLS | Chopas James George | — | Sep 15, 2025 | Proposed Sale | $24.19 | 189 | $4.6K | — | |
APLS | Chopas James George | — | Sep 2, 2025 | Proposed Sale | $28.08 | 548 | $15.4K | — | |
APLS | Chopas James George | — | Mar 17, 2025 | Proposed Sale | $24.82 | 183 | $4.5K | — | |
APLS | Chopas James George | — | Jan 22, 2025 | Proposed Sale | $30.43 | 1,096 | $33.3K | — | |
APLS | Chopas James George | — | Jan 17, 2025 | Proposed Sale | $29.96 | 715 | $21.4K | — | |
APLS | Chopas James George | — | Jan 13, 2025 | Proposed Sale | $28.70 | 798 | $22.9K | — | |
APLS | Chopas James George | — | Sep 16, 2024 | Proposed Sale | $36.21 | 192 | $7.0K | — | |
APLS | Chopas James George | — | Sep 3, 2024 | Proposed Sale | $39.49 | 550 | $21.7K | — |